IOL Chemicals and Pharmaceuticals Limited (IOLCP.BO)
INR 438.8
(8.1%)
INR 438.8
(8.1%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.87 Billion | 1.22 Billion | 930.5 Million | 3.79 Billion | 4.7 Billion | 2.73 Billion |
| Net Income | 1.34 Billion | 1.88 Billion | 2.24 Billion | 5.71 Billion | 5.33 Billion | 3.36 Billion |
| Depreciation & Amortization | 629.1 Million | 461.6 Million | 432.6 Million | 389.2 Million | 357.3 Million | 322.9 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 903.3 Million | -636.9 Million | -1.02 Billion | -765.1 Million | 27.8 Million | -776.4 Million |
| Other non-cash items | 352.8 Million | -488.5 Million | -727.2 Million | -1.54 Billion | -1 Billion | -176.3 Million |
| Investing Cash Flow | -2.04 Billion | -1.2 Billion | -1.2 Billion | -3.17 Billion | -1.84 Billion | -630.4 Million |
| Investments in PPE | -2.74 Billion | -2.11 Billion | -1.53 Billion | -1.08 Billion | -802.8 Million | -605.3 Million |
| Acquisitions | 18.5 Million | 22.2 Million | 18.9 Million | 7.8 Million | 6 Million | 7.6 Million |
| Investment purchases | -5.4 Million | -176.1 Million | -11.4 Million | -2.21 Billion | -1.02 Billion | -45.7 Million |
| Sales/Maturities of investments | 681 Million | 978.4 Million | 235.5 Million | 600 Thousand | 39.7 Million | 58.7 Million |
| Other Investing Activities | 900 Thousand | 93.7 Million | 84.7 Million | 114.1 Million | -58.5 Million | -45.7 Million |
| Financing Cash Flow | -764 Million | -41.1 Million | -16.4 Million | -582.8 Million | -2.71 Billion | -1.97 Billion |
| Debt repayment | -468.7 Million | -368.8 Million | -427.5 Million | -559.9 Million | -2.28 Billion | -1.21 Billion |
| Dividends payments | -293.5 Million | -235 Million | -352.2 Million | -234.8 Million | -205.7 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 279.5 Million | - | 60 Million |
| Other Financing Activities | -162.8 Million | 562.7 Million | 763.3 Million | -67.6 Million | -227.2 Million | -822.9 Million |
| Accounts receivables | 276.6 Million | -430.7 Million | -1.7 Billion | -295 Million | -503.6 Million | -779 Million |
| Accounts payables | 1.61 Billion | -1.04 Billion | 1.83 Billion | 606.1 Million | 518 Million | -183.3 Million |
| Inventory | -993.2 Million | 843.7 Million | -1.14 Billion | -1.07 Billion | 13.4 Million | 185.9 Million |
| Other working capital | 1.61 Billion | - | - | - | - | - |
| Cash at beginning of period | 26.4 Million | 32.3 Million | 323.4 Million | 280.9 Million | 134.1 Million | 7.4 Million |
| Cash at end of period | 1.42 Billion | 13.9 Million | 32.3 Million | 323.4 Million | 280.9 Million | 134.1 Million |
| Capital Expenditure | -2.74 Billion | -2.11 Billion | -1.53 Billion | -1.08 Billion | -802.8 Million | -605.3 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.4 Billion | -18.4 Million | -291.1 Million | 42.5 Million | 146.8 Million | 126.7 Million |
| Free Cash Flow | 132.9 Million | -895.5 Million | -602.4 Million | 2.71 Billion | 3.9 Billion | 2.12 Billion |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.34 Billion | 230.8 Million | 378.7 Million | 458.6 Million | 1.88 Billion | 647.8 Million |
| Depreciation & Amortization | 629.1 Million | 163.4 Million | 156.9 Million | 144.5 Million | 461.6 Million | 121.1 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 903.3 Million | - | - | - | -636.9 Million | - |
| Other non-cash items | 352.8 Million | -163.4 Million | -156.9 Million | -144.5 Million | -488.5 Million | -121.1 Million |
| Investing Cash Flow | -2.04 Billion | - | - | - | -1.2 Billion | - |
| Investments in PPE | -2.74 Billion | - | - | - | -2.11 Billion | - |
| Acquisitions | 18.5 Million | - | - | - | 22.2 Million | - |
| Investment purchases | -5.4 Million | - | - | - | -176.1 Million | - |
| Sales/Maturities of investments | 681 Million | - | - | - | 978.4 Million | - |
| Other Investing Activities | 900 Thousand | - | - | - | 93.7 Million | - |
| Financing Cash Flow | -764 Million | - | - | - | -41.1 Million | - |
| Debt repayment | -468.7 Million | - | - | - | -368.8 Million | - |
| Dividends payments | -293.5 Million | - | - | - | -235 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | 562.7 Million | - |
| Accounts receivables | 276.6 Million | - | - | - | -430.7 Million | - |
| Accounts payables | 1.61 Billion | - | - | - | -1.04 Billion | - |
| Inventory | -993.2 Million | - | - | - | 843.7 Million | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 26.4 Million | 587.1 Million | 208.4 Million | 26.4 Million | 32.3 Million | -621.4 Million |
| Cash at end of period | 1.42 Billion | 230.8 Million | 587.1 Million | 458.6 Million | 13.9 Million | 26.4 Million |
| Capital Expenditure | -2.74 Billion | - | - | - | -2.11 Billion | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.4 Billion | -356.3 Million | 378.7 Million | 432.2 Million | -18.4 Million | 647.8 Million |
| Free Cash Flow | 132.9 Million | 230.8 Million | 378.7 Million | 458.6 Million | -895.5 Million | 647.8 Million |
0A7O
AMC
VBAM
MISHKA
KDH
WINDLAS